Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Market Cap	$177.38M	P/E Ratio	N/A
52W High	$5.92	52W Low	$0.92
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	-4.2%	52W Position	7.9%
Overall Score	31	Value Score	45
Quality Score	--	Technical Score	18

EPS Current Est	$-0.61	EPS Next Est	$-0.49
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	STIM	$1.31	+0.77%	1.35M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	STIM	$1.31	+0.8%	1.35M
3
4
5
6

STIM

STIM

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Neuronetics Inc. Data in Excel

Get Neuronetics Inc. Data in Excel